Carregant...
Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension
Prostacyclins are the mainstay treatment for patients with severe pulmonary arterial hypertension. This case highlights the transition from selexipag to oral treprostinil. Our patient improved both subjectively and objectively. Cardiac output and index, as measured by the echocardiogram, improved 12...
Guardat en:
| Publicat a: | Pulm Circ |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7144673/ https://ncbi.nlm.nih.gov/pubmed/32292582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894019898032 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|